Group Overview & Strategy



OUR BUSINESS MODEL


Sales, Marketing & Medical

24%

of Group
Operating Profit

Healthcare Supply Chain

57%

of Group
Operating Profit

Packaging & Specialty

19%

of Group
Operating Profit

Key Services

  • Sales channel solutions
  • Medical Communications
  • Event Management
  • Medical information Pharmacovigilence

Key Services

  • Logistics services
  • Logistics administration
  • Information services
  • Admin services & tech support

Key Services

  • Formulation services
  • Packaging solutions
  • Serialisation services
  • Batch storage solutions
map
OUR STRATEGIC AMBITIONS
Combine our services internationally around the needs of healthcare companies
Double the size of the Group over the next 5 years through performance led growth
Increase the pace of internationalisation of the Group
Enter emerging markets as well as established ones
Provide services in the pre-approval as well as post-approval stage of a drug’s lifecycle
Be a world leader in quality, safety and compliance as a route to business development
OUR CORE CAPABILITIES
In depth knowledge, understanding of and focus on healthcare
Financially stable service provider operating a unique footprint of services in vital international markets
Commitment to and track record of best-in-class quality, safety, and compliance in life sciences
Technical expertise in highly regulated supply chain, packaging, marketing and regulatory services in healthcare
Extensive relationships with life science clients across multiple markets
Excellent facilities, systems and people

WHERE TO NEXT...

Deliver integration benefits from recent acquisitions.

Deliver on earnings growth story coupled with continued progressive dividend policy.

Underline our position as ‘an international healthcare services group, headquartered in Ireland’.

Continue to internationalise our services across each of our business platforms.